Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Correction

Correction: COVID-19 outbreaks surveillance through text mining applied to electronic health records

Authors: Hermano Alexandre Lima Rocha, Erik Zarko Macêdo Solha, Vasco Furtado, Francion Linhares Justino, Lucas Arêa Leão Barreto, Ronaldo Guedes da Silva, Ítalo Martins de Oliveira, David Westfall Bates, Luciano Pamplona de Góes Cavalcanti, Antônio Silva Lima Neto, Erneson Alves de Oliveira

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Excerpt

CorrectionBMC Infect Dis 24, 359 (2024)
Metadata
Title
Correction: COVID-19 outbreaks surveillance through text mining applied to electronic health records
Authors
Hermano Alexandre Lima Rocha
Erik Zarko Macêdo Solha
Vasco Furtado
Francion Linhares Justino
Lucas Arêa Leão Barreto
Ronaldo Guedes da Silva
Ítalo Martins de Oliveira
David Westfall Bates
Luciano Pamplona de Góes Cavalcanti
Antônio Silva Lima Neto
Erneson Alves de Oliveira
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09292-2

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine